ACUMEN PHARMACEUTICALS INC's ticker is ABOS and the CUSIP is 00509G209. A total of 66 filers reported holding ACUMEN PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 1.12 and the average weighting 0.2%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MORGAN STANLEY | 22,239 | $92,293 | 0.00% |
| WELLINGTON MANAGEMENT GROUP LLP | 104,359 | $433,090 | 0.00% |
| BlackRock Inc. | 583,414 | $2,421,168 | 0.00% |
| Zurcher Kantonalbank (Zurich Cantonalbank) | 3,393 | $14,081 | 0.00% |
| Citadel Advisors | 24,400 | $101,260 | 0.00% |
| Citadel Advisors | 15,200 | $63,080 | 0.00% |
| Citadel Advisors | 232 | $963 | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 105,800 | $439,070 | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 195,000 | $809,250 | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 177,779 | $737,783 | 0.00% |
| DekaBank Deutsche Girozentrale | 40,000 | $167 | 0.00% |
| TWO SIGMA ADVISERS, LP | 20,088 | $83,365 | 0.00% |
| Daiwa Securities Group Inc. | 165 | $1 | 0.00% |
| Tower Research Capital LLC (TRC) | 2,128 | $8,831 | 0.00% |
| Qube Research & Technologies Ltd | 26,113 | $108,369 | 0.00% |
External links
This page lists ACUMEN PHARMACEUTICALS INC's shareholders in Q3 2023. To view ACUMEN PHARMACEUTICALS INC's shareholder history, click here.